| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/24/2003 | WO2003053361A3 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE |
| 12/24/2003 | WO2003048148A9 Statin-like compounds |
| 12/24/2003 | WO2003047611A3 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 12/24/2003 | WO2003040174A3 Substituted amino ketone compounds |
| 12/24/2003 | WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 12/24/2003 | WO2003035046A3 Salts formed of an at1-receptor antagonist and a cardiovascular agent |
| 12/24/2003 | WO2003032963A3 Method of reducing type 2 diabetes in high risk patients |
| 12/24/2003 | WO2003022239A3 Stable water in oil aminophylline emulsions |
| 12/24/2003 | WO2002102997A3 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/24/2003 | WO2002092764A3 Transgenic animal model of bone mass modulation |
| 12/24/2003 | WO2002068676A3 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 12/24/2003 | WO2002057435A3 Bifunctional fusion proteins with glucocerebrosidase activity |
| 12/24/2003 | WO2002034204A8 Calcilytic compounds |
| 12/24/2003 | WO2001085193A8 Method for promoting neovascularization using a tweak agonist and an angiogenic factor |
| 12/24/2003 | WO2001052878A8 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 12/24/2003 | DE10225635C1 N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung N-Benzoylureido-cinnamic acid derivatives, processes for their preparation and their use |
| 12/24/2003 | CN1463191A Low hygroscopic aripiprazole drug substance and processes for prepn. thereof |
| 12/24/2003 | CN1462634A Method of producing tables of biology salcium with multienzyme |
| 12/24/2003 | CN1462622A Method of preparing biologic calcium from snails |
| 12/24/2003 | CN1462620A Powder of flenabane and its preparation method as well as application in making drugs |
| 12/24/2003 | CN1131868C 作为药物的三环△3－哌啶 As a tricyclic drug △ 3- piperidine |
| 12/24/2003 | CN1131860C 依来曲普坦氢溴酸盐一水合物 According to eletriptan hydrobromide monohydrate |
| 12/24/2003 | CA2489870A1 Low molecular weight oversulfated polysaccharide |
| 12/24/2003 | CA2489866A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 12/24/2003 | CA2489791A1 Combinations of pde-v inhibitors and nk1 antagonists for the treatment of anxiety or depression |
| 12/24/2003 | CA2489466A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 12/24/2003 | CA2489463A1 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 12/24/2003 | CA2489447A1 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 12/24/2003 | CA2489312A1 Modulation of activation of glucocorticoid receptors .beta.-breakdown products of glucocorticoids |
| 12/24/2003 | CA2489292A1 Vectors for expression of hml-2 polypeptides |
| 12/24/2003 | CA2489250A1 Composition comprising viscous fibers and viscosity-lowering proteins |
| 12/24/2003 | CA2489247A1 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 12/24/2003 | CA2489245A1 Fluorinated cycloalkyl-derivatized benzoylguanidines and their use as a medicament |
| 12/24/2003 | CA2489182A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/24/2003 | CA2489130A1 Preparations containing conjugated linoleic alcohol |
| 12/24/2003 | CA2489098A1 Bazedoxifene treatment regimens |
| 12/24/2003 | CA2488802A1 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | CA2488708A1 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/24/2003 | CA2488699A1 Indole, indazole, and benzazole derivative |
| 12/24/2003 | CA2488117A1 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 12/24/2003 | CA2487948A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators |
| 12/24/2003 | CA2486557A1 Calcium salts of indole derived statins |
| 12/24/2003 | CA2485346A1 Human adam-10 inhibitors |
| 12/23/2003 | US6667345 Derivatives of C2-substituted indan-1-ol systems for the prophylaxis or treatment of obesity |
| 12/23/2003 | US6667342 Benzenesulfonamide-derivatives and their use as medicaments |
| 12/23/2003 | US6667334 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 12/23/2003 | US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 12/23/2003 | US6667328 Such as 2-(N-Cyanoimino)-5-((E)-4-styrylbenzylidene)thiazol-idin-4-one; prophylaxis of hypolipidemic/hypoglycemic, hyper-/hypo-cholesterolemia activity |
| 12/23/2003 | US6667327 Pyridine amido derivatives |
| 12/23/2003 | US6667319 Neuropeptide Y Y5 receptor antagonists |
| 12/23/2003 | US6667315 Pyridoxine phosphonate analogues such as, for example, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)alkylphosphonates, and (2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)azaalkylphosphonates) |
| 12/23/2003 | US6667313 8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators |
| 12/23/2003 | US6667304 Affinity for melatonin receptors; sleep disorders; N-(2-(2-methoxy-6H-pyrido(2',3':4,5)pyrrolo(2,1-a)isoindol-11 -yl)ethyl)acetamide; N-(2-(3-methoxy-6,7,8,9-tetrahydropyrido (3,2-b)indolizin-5-yl) ethyl)acetamide |
| 12/23/2003 | US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 12/23/2003 | US6667300 Purinyl substituted quinazoline-4-one derivatives |
| 12/23/2003 | US6667064 Composition and method for treatment of hypertriglyceridemia |
| 12/23/2003 | CA2294251C Satiety product |
| 12/23/2003 | CA2268439C Citrus peel extract as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor |
| 12/23/2003 | CA2116387C Oxazolidinedione derivatives, their production and use |
| 12/18/2003 | WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 12/18/2003 | WO2003104473A2 Galactosyl isomalt, method for production and use thereof |
| 12/18/2003 | WO2003104407A2 T cell receptor cdr3 sequences and methods for detection |
| 12/18/2003 | WO2003104260A2 Pharmaceutical formulation |
| 12/18/2003 | WO2003104255A2 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives |
| 12/18/2003 | WO2003104254A2 Novel derivatives of androstane and androstene with ascorbic a cid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 12/18/2003 | WO2003104250A1 New compounds for modulating the activity of exchange proteins directly activated by camp (epacs) |
| 12/18/2003 | WO2003104235A1 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]pyrazines and decahydropyrazino[1,2-a]azepines |
| 12/18/2003 | WO2003104230A1 Bicyclic pyrimidine derivatives |
| 12/18/2003 | WO2003104229A1 Novel fused imidazole derivative |
| 12/18/2003 | WO2003104226A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 12/18/2003 | WO2003104225A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 12/18/2003 | WO2003104223A1 Pyrazole-derivatives as p38 kinase inhibitors |
| 12/18/2003 | WO2003104222A1 Bisindolyl-maleimid derivatives as kinase inhibitors |
| 12/18/2003 | WO2003104219A1 Nf-kb inhibitors |
| 12/18/2003 | WO2003104218A1 Nf-:b inhibitors |
| 12/18/2003 | WO2003104208A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 12/18/2003 | WO2003104207A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 12/18/2003 | WO2003104205A1 Aryloximes |
| 12/18/2003 | WO2003104204A1 Pyridazine derivatives |
| 12/18/2003 | WO2003104203A1 Therapeutic molecules and methods-1 |
| 12/18/2003 | WO2003104196A1 Non-peptidic brs-3 agonists |
| 12/18/2003 | WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans |
| 12/18/2003 | WO2003104188A1 N-benzoylureidocinnamate derivatives, method for production and use thereof |
| 12/18/2003 | WO2003103772A1 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma |
| 12/18/2003 | WO2003103704A2 Proteins involved in the regulation of energy homeostasis |
| 12/18/2003 | WO2003103703A1 Remedy for bone mtabolic diseases |
| 12/18/2003 | WO2003103701A1 Compositions and methods for treating diabetes |
| 12/18/2003 | WO2003103697A2 Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity |
| 12/18/2003 | WO2003103669A1 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists |
| 12/18/2003 | WO2003103663A2 Substituted pyrrolines as kinase inhibitors |
| 12/18/2003 | WO2003103661A1 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES |
| 12/18/2003 | WO2003103660A1 Substituted phenylsulfonamide inhibitors of beta amyloid production |
| 12/18/2003 | WO2003103640A1 Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"), novel combinations thereof as well as manufacturing of these pharmaceutical compositions |
| 12/18/2003 | WO2003103633A1 Nanoparticulate sterol formulations and sterol combinations |
| 12/18/2003 | WO2003103632A1 Nanoparticulate polycosanol formulations and novel polycosanol combinations |
| 12/18/2003 | WO2003103603A2 Novel formate salt of o-desmethyl-venlafaxine |
| 12/18/2003 | WO2003103585A2 Methods of treating angiogenesis, tumor growth, and metastasis |
| 12/18/2003 | WO2003103577A2 Novel recombinant anticoagulant proteins |
| 12/18/2003 | WO2003097052A3 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 12/18/2003 | WO2003082817A3 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |